NovaBay Pharmaceuticals, Inc. (NBY): Price and Financial Metrics
NBY Price/Volume Stats
| Current price | $0.58 | 52-week high | $3.14 |
| Prev. close | $0.59 | 52-week low | $0.36 |
| Day low | $0.56 | Volume | 20,400 |
| Day high | $0.59 | Avg. volume | 139,512 |
| 50-day MA | $0.57 | Dividend yield | N/A |
| 200-day MA | $0.61 | Market Cap | 3.37M |
NBY Stock Price Chart Interactive Chart >
NovaBay Pharmaceuticals, Inc. (NBY) Company Bio
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes non-antibiotic anti-infective products for the eye care market in the United States. The company was founded in 2000 and is based in Emeryville, California.
NBY Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NBY Price Returns
| 1-mo | 1.72% |
| 3-mo | -3.33% |
| 6-mo | -2.06% |
| 1-year | -78.60% |
| 3-year | -99.79% |
| 5-year | -99.95% |
| YTD | -3.49% |
| 2024 | -91.58% |
| 2023 | -89.54% |
| 2022 | -85.21% |
| 2021 | -45.97% |
| 2020 | 8.91% |